Additional file 1: of Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study

Alberto Martini (8758); Anasuya Hazra (4722045); Charles Mebus (4722036); Christine Alvey (4722042); Daniel Kingsbury (3689920); Daniel Lovell (3584141); Elzbieta Smolewska (4722039); Gerd Horneff (3415988); Hermine Brunner (3580763); Ivan Foeldvari (4578778); Manisha Lamba (3774478); Min Wang (21070); Nicolino Ruperto (3689917); Nikolay Tzaribachev (4722033); Ricardo Suehiro (4722030); Richard Vehe (4239064); Rong Wang (59795); Sriram Krishnaswami (3513092); Thomas Stock (2469904); Zbigniew Zuber (4722027)

Additional file 1: of Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study

Abstract

Inclusion criteria for the long-term extension study, dosing scheme, and descriptive summary of plasma tofacitinib pharmacokinetic parameter values by gender. (PDF 39Â kb

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/57390...

Last time updated on 12/02/2018